Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$634,508
-$141,904 QoQ
Shares Held
26,350
-4.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,593
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Violich Capital Management, Inc. holds $62,484,887 across 7 Drug Manufacturers - General names. PFE ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
109,254 | $27,492,676 | |
| 2 | JNJ |
Johnson & Johnson
|
87,990 | $22,346,820 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,257 | $6,458,024 | |
| 4 | AMGN |
Amgen Inc
|
9,350 | $3,385,822 | |
| 5 | LLY |
ELI LILLY & Co
|
1,291 | $1,548,464 | |
| 6 | PFE |
Pfizer Inc
This page
|
26,350 | $634,508 | |
| 7 | NVS |
Novartis AG
|
3,947 | $618,573 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $634,508 | 26,350 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $776,412 | 27,650 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $713,385 | 28,650 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $790,822 | 31,037 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $752,336 | 31,037 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,044,945 | 41,237 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,094,017 | 41,237 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,361,250 | 47,037 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,311,394 | 46,869 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,300,614 | 46,869 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $924,706 | 32,119 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,136,105 | 34,251 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,256,326 | 34,251 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,397,440 | 34,251 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,755,021 | 34,251 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,498,823 | 34,251 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,795,779 | 34,251 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $1,773,174 | 34,251 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,986,264 | 33,637 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,446,727 | 33,637 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $916,344 | 23,400 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $847,782 | 23,400 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $861,354 | 23,400 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $858,779 | 23,400 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $791,340 | 24,200 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $789,886 | 24,200 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||